These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32294321)

  • 1. Impact of the COVID-19 pandemic on therapeutic choices in thrombosis-hemostasis.
    Hermans C; Lambert C
    J Thromb Haemost; 2020 Jul; 18(7):1794-1795. PubMed ID: 32294321
    [No Abstract]   [Full Text] [Related]  

  • 2. Current Perspectives of Anticoagulation in Patients With COVID-19.
    Gavioli EM; Sikorska G; Man A; Rana J; Vider E
    J Cardiovasc Pharmacol; 2020 Aug; 76(2):146-150. PubMed ID: 32569013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous Thromboembolism and Heparin Use in COVID-19 Patients: Juggling between Pragmatic Choices, Suggestions of Medical Societies and the Lack of Guidelines.
    Porfidia A; Pola R
    J Thromb Thrombolysis; 2020 Jul; 50(1):68-71. PubMed ID: 32367471
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemorrhagic stroke and anticoagulation in COVID-19.
    Dogra S; Jain R; Cao M; Bilaloglu S; Zagzag D; Hochman S; Lewis A; Melmed K; Hochman K; Horwitz L; Galetta S; Berger J
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104984. PubMed ID: 32689588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.
    Speed V; Patel RK; Byrne R; Roberts LN; Arya R
    Thromb Res; 2020 Aug; 192():73-74. PubMed ID: 32425265
    [No Abstract]   [Full Text] [Related]  

  • 6. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
    Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
    J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
    [No Abstract]   [Full Text] [Related]  

  • 8. Long lasting hypercoagulability after subclinical COVID-19.
    Ferroli P; Villa C; Ciuffi A; Gubertini G; Broggi M
    J Thromb Thrombolysis; 2020 Nov; 50(4):822-824. PubMed ID: 32757154
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin resistance in COVID-19 patients in the intensive care unit.
    White D; MacDonald S; Bull T; Hayman M; de Monteverde-Robb R; Sapsford D; Lavinio A; Varley J; Johnston A; Besser M; Thomas W
    J Thromb Thrombolysis; 2020 Aug; 50(2):287-291. PubMed ID: 32445064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2020 - Year of COVID-19.
    Lillicrap D; Morrissey JH
    J Thromb Haemost; 2020 Sep; 18(9):2081. PubMed ID: 32881334
    [No Abstract]   [Full Text] [Related]  

  • 11. ISTH DIC subcommittee communication on anticoagulation in COVID-19.
    Thachil J; Juffermans NP; Ranucci M; Connors JM; Warkentin TE; Ortel TL; Levi M; Iba T; Levy JH
    J Thromb Haemost; 2020 Sep; 18(9):2138-2144. PubMed ID: 32881336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis.
    Thachil J; Longstaff C; Favaloro EJ; Lippi G; Urano T; Kim PY;
    J Thromb Haemost; 2020 Sep; 18(9):2408-2411. PubMed ID: 32881272
    [No Abstract]   [Full Text] [Related]  

  • 13. Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection.
    Nauka PC; Oran E; Chekuri S
    Thromb Res; 2020 Aug; 192():27-28. PubMed ID: 32419710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19.
    Bautista-Vargas M; Bonilla-Abadía F; Cañas CA
    J Thromb Thrombolysis; 2020 Oct; 50(3):479-483. PubMed ID: 32519164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and venous thromboembolism: current insights and prophylactic strategies.
    Ambrosino P; Di Minno A; Maniscalco M; Di Minno MND
    Ann Med; 2020 Sep; 52(6):239-242. PubMed ID: 32619360
    [No Abstract]   [Full Text] [Related]  

  • 17. Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19.
    Busch MH; Timmermans SAMEG; Nagy M; Visser M; Huckriede J; Aendekerk JP; de Vries F; Potjewijd J; Jallah B; Ysermans R; Oude Lashof AML; Breedveld PH; van de Poll MCG; van de Horst ICC; van Bussel BCT; Theunissen ROMFIH; Spronk HMH; Damoiseaux JGMC; Ten Cate H; Nicolaes GAF; Reutelingsperger CP; van Paassen P
    Circulation; 2020 Nov; 142(18):1787-1790. PubMed ID: 32946302
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.
    Wanderer JP; Nathan N
    Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849
    [No Abstract]   [Full Text] [Related]  

  • 19. Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
    Ogawa Y; Nagata T; Akiyama T; Nishida K; Kumasawa J; Kohno M; Kohata H; Gohma I
    J Thromb Thrombolysis; 2020 Nov; 50(4):1012-1014. PubMed ID: 32780355
    [No Abstract]   [Full Text] [Related]  

  • 20. Spontaneous Major Hemorrhage in COVID-19 Patients: Another Brick in the Wall of SARS-CoV-2-Associated Coagulation Disorders?
    Palumbo D; Guazzarotti G; De Cobelli F
    J Vasc Interv Radiol; 2020 Sep; 31(9):1494-1496. PubMed ID: 32768277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.